Wasting cash--the decline of the British biotech sector.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19513054.
- Also identified by DOI 10.1038/nbt0609-531.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.
Medical subject headings
- Biotechnology